In vitro deacetylation of N ‐acetylserotonin by arylacetamide deacetylase
Journal of Pineal Research · 2023
DOI: 10.1111/jpi.12870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, 2023. Verfasst von Zheping Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Carboxylic Ester Hydrolases, Melatonin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIH, U.S. Department of Defense.
Abstract (Originalsprache)
Arylacetamide deacetylase (AADAC) is a deacetylation enzyme present in the mammalian liver, gastrointestinal tract, and brain. During our search for mammalian enzymes capable of metabolizing N ‐acetylserotonin (NAS), AADAC was identified as having the ability to convert NAS to serotonin. Both human and rodent recombinant AADAC proteins can deacetylate NAS in vitro, although the human AADAC shows markedly higher activity compared with rodent enzyme. The AADAC‐mediated deacetylation reaction can be potently inhibited by eserine in vitro. In addition to NAS, recombinant hAADAC can deacetylate melatonin (to form 5‐methoxytryptamine) and N ‐acetyltryptamine (NAT) (to form tryptamine). In addition to the in vitro deacetylation of NAS by the recombinant AADAC proteins, liver (mouse and human) and brain (human) extracts were able to deacetylate NAS; these activities were sensitive to eserine. Taken together, these results demonstrate a new role for AADAC and suggest a novel pathway for the AADAC‐mediated metabolism of pineal indoles in mammals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Harbin Center for Disease Control and Prevention, Bacteriologic Laboratory, Harbin Center for Disease Control and Prevention, Harbin, Heilongjiang Province, China.
- Faculty of Pharmaceutical Sciences, Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Kakuma-machi, Japan.
- WPI Nano Life Science Institute (WPI-Nano LSI), Kanazawa University, Kanazawa, Kakuma-machi, Japan.
Förderung
- NINDS NIH HHS
- NIH
- U.S. Department of Defense
Zitieren
APA
Huang, Z., Li, Y., Konishi, K., Sakai, Y., Tashiro, K., Fukami, T., & Borjigin, J. (2023). In vitro deacetylation of N ‐acetylserotonin by arylacetamide deacetylase. Journal of Pineal Research. https://doi.org/10.1111/jpi.12870
Vancouver
Huang Z, Li Y, Konishi K, Sakai Y, Tashiro K, Fukami T, et al. In vitro deacetylation of N ‐acetylserotonin by arylacetamide deacetylase. Journal of Pineal Research. 2023. doi:10.1111/jpi.12870
BibTeX
@article{Huang2023,
author = {Huang, Zheping and Li, Yu and Konishi, Keigo and Sakai, Yoshiyuki and Tashiro, Kiyomichi and Fukami, Tatsuki and Borjigin, Jimo},
title = {In vitro deacetylation of N ‐acetylserotonin by arylacetamide deacetylase},
journal = {Journal of Pineal Research},
year = {2023},
doi = {10.1111/jpi.12870}
}
EUVIMED